79 related articles for article (PubMed ID: 15913565)
21. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
22. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
23. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
24. A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia.
Cui Y; Liao XX; Liu W; Guo RX; Wu ZZ; Zhao CM; Chen PX; Feng JQ
Brain Behav Immun; 2008 Jan; 22(1):114-23. PubMed ID: 17919885
[TBL] [Abstract][Full Text] [Related]
25. Activity of adenylyl cyclase and protein kinase A contributes to morphine-induced spinal apoptosis.
Lim G; Wang S; Lim JA; Mao J
Neurosci Lett; 2005 Dec; 389(2):104-8. PubMed ID: 16102899
[TBL] [Abstract][Full Text] [Related]
26. Implication of spinal protein kinase Cgamma isoform in activation of the mouse brain by intrathecal injection of the protein kinase C activator phorbol 12,13-dibutyrate using functional magnetic resonance imaging analysis.
Niikura K; Kobayashi Y; Okutsu D; Furuya M; Kawano K; Maitani Y; Suzuki T; Narita M
Neurosci Lett; 2008 Mar; 433(1):6-10. PubMed ID: 18242849
[TBL] [Abstract][Full Text] [Related]
27. ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes.
Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Nagahira A; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
Immunol Lett; 2009 Feb; 122(2):193-7. PubMed ID: 19195485
[TBL] [Abstract][Full Text] [Related]
28. [Effects of paroxetine on protein kinase PKA, PKC and CaMKII activity in different brain regions in a rat depression model].
Zheng H; Ma GY; Fu XC; DU HG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1223-5. PubMed ID: 18676269
[TBL] [Abstract][Full Text] [Related]
29. Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions.
Rubino T; Vigano' D; Massi P; Spinello M; Zagato E; Giagnoni G; Parolaro D
Neuropharmacology; 2000 Apr; 39(7):1331-6. PubMed ID: 10760375
[TBL] [Abstract][Full Text] [Related]
30. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice.
Brand PA; Paris A; Bein B; Meybohm P; Scholz J; Ohnesorge H; Tonner PH
Anesth Analg; 2008 Jul; 107(1):102-6. PubMed ID: 18635473
[TBL] [Abstract][Full Text] [Related]
31. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE
J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275
[TBL] [Abstract][Full Text] [Related]
32. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.
Boucher AA; Hunt GE; Karl T; Micheau J; McGregor IS; Arnold JC
Neuroscience; 2007 Nov; 149(4):861-70. PubMed ID: 17905522
[TBL] [Abstract][Full Text] [Related]
33. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
Magour S; Coper H; Fähndrich C
Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
[TBL] [Abstract][Full Text] [Related]
34. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice.
Büyükafşar K; Yalçin I; Kurt AH; Tiftik RN; Sahan-Firat S; Aksu F
Eur J Pharmacol; 2006 Jul; 541(1-2):49-52. PubMed ID: 16750189
[TBL] [Abstract][Full Text] [Related]
35. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.
Lu T; Newton C; Perkins I; Friedman H; Klein TW
Eur J Pharmacol; 2006 Feb; 532(1-2):170-7. PubMed ID: 16443217
[TBL] [Abstract][Full Text] [Related]
36. Cyclic adenosine 3',5'monophosphate/protein kinase A and mitogen-activated protein kinase 3/1 pathways are involved in adenylate cyclase-activating polypeptide 1-induced common alpha-glycoprotein subunit gene (Cga) expression in mouse pituitary gonadotroph LbetaT2 cells.
Harada T; Kanasaki H; Mutiara S; Oride A; Miyazaki K
Biol Reprod; 2007 Oct; 77(4):707-16. PubMed ID: 17596563
[TBL] [Abstract][Full Text] [Related]
37. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Jul; 567(1-2):125-30. PubMed ID: 17498686
[TBL] [Abstract][Full Text] [Related]
38. A pharmacogenetic analysis of the effects of tetrahydrocannabinol (delta 9THC) on brain gamma glutamyl transpeptidase.
Reyes E; Jones BC
Neurobehav Toxicol Teratol; 1985; 7(2):167-9. PubMed ID: 2860574
[TBL] [Abstract][Full Text] [Related]
39. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
[TBL] [Abstract][Full Text] [Related]
40. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
